3Vitali C,Bombardieri S,Jonsson R. Classication crite-ria for Sjo?gren's syndrome:a revised version of the Europe-an criteria proposed by the American-European Consensus Group[J].{H}ANNALS OF THE RHEUMATIC DISEASES,2002.554-558.
4Simonneau G,Galie N,Rubin LJ. Clinic classification of pulmonary hypertension[J].{H}Journal of the America College of Cardiology,2004,(suppl):5-12.
5Gyo?ngyo?si M,Pokorny G,Jambrik Z. Cardiac mani-festations in primary Sjo?gren's syndrome[J].{H}ANNALS OF THE RHEUMATIC DISEASES,1996,(07):450-454.
6Okawa-Takatsuji M,Aotsuka S,Fujinami M. Up-regu-lation of intercellular adhesion molecule-l(ICAM-1),en-dothelial leucocyte adhesion molecule-1(ELAM-1) and classⅡMHC molecules on pulmonary artery endothelial cells by antibodies against Ul-ribonucleoprotein[J].{H}Clinical and Experimental Immunology,1999.174-180.
7Nishimaki T,Aotsuka S,Kondo H. Immunological anal-ysis of pulmonary hypertension in connective tissue dis-eases[J].{H}Journal of Rheumatology,1999.2357-2362.
8Humbert M,Sitbon O,Simnoneau G. Drug therapy:treat-ment of pulmonary arterial hypertension[J].{H}New England Journal of Medicine,2004.1435-1436.
